A carregar...
Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective
Infection with respiratory syncytial virus (RSV) is one of the major causes globally of childhood respiratory morbidity and hospitalization. Palivizumab, a humanized monoclonal antibody, has been recommended for high risk infants to prevent severe RSV-associated respiratory illness. This recommendat...
Na minha lista:
| Publicado no: | Int J Pediatr |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4274815/ https://ncbi.nlm.nih.gov/pubmed/25548575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/571609 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|